Jennifer L. Good, President & CEO at Trevi Therapeutics, Inc. (TRVI), sold 5,263 shares at $6.58 ($35K) on 2025-03-21, disclosed to the SEC on 2025-03-25.
Open-market sale of $35k TRVI by President & CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| TRVI | SELL | 2024-09-09 | $18K | — | Filing → |
| TRVI | SELL | 2024-09-05 | $295K | — | Filing → |
| RYTM | SELL | 2024-08-28 | $1.5M | — | Filing → |